Bioretec Oy

BRETEC · Nasdaq Helsinki · Healthcare

0.03EUR −1.5%last day

Price as of 2 October 2026

The price over the past year, with dividends: −97.9%

Performance

1 month

+23.1%

1 year

−97.9%

3 years, per year

−78.6%

5 years, per year

−61.0%

Largest fall, 3 years

−99.6%

Below the peak now

−99.2%

Volatility, 1 year

499.2%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

2.0

Dividend yield

0.0%

Return on equity

−26.1%

Net margin

−147.1%

Market value

40 m USD

Quality, value and trend

Where Bioretec stands against every Nordic stock today. 100 is best.

Quality36

Profitability and a sound balance sheet over time. Better than 36% of Nordic stocks.

Value13

The price measured against earnings, assets and cash flow. Better than 13% of Nordic stocks.

Trend26

The price development over the past year. Better than 26% of Nordic stocks.

Combined8

Quality, value and trend together. Better than 8% of Nordic stocks.

About Bioretec

Bioretec Oy is a company in healthcare, listed on Nasdaq Helsinki. The share trades in EUR.

Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis